Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Promoting collateral formation in type 2 diabetes mellitus using ultra-small nanodots with autophagy activation and ROS scavenging

Fig. 4

MoS2 NDs improved collateral formation in diabetic mice. (A) Illustration of time points of MoS2 NDs injection and laser Doppler imaging in diabetic mice. (B) Representative H&E images of muscles harvested at the indicated time with PBS and MoS2 NDs. (C) Quantification of the regenerating area at different time points, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (D) Quantification of the necrotic area at indicated times from H&E staining, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (E) Representative images of hindlimb blood perfusion with PBS and MoS2 NDs at indicated times. (F) Quantification of hindlimb blood perfusion at the indicated times, n = 5, and P values were calculated by two-way ANOVA with Bonferroni post-hoc test. (G) Representative DHE staining images and quantification of DHE+ area on day 7, n = 9, P values were calculated by t-test. (H) Representative CD31+/α-SMA+ immunofluorescent images and quantification of CD31+ area and α-SMA area on transverse cross sections on day 7, n = 9, and P values were calculated by t-test. All data are presented as the mean ± SD.

Back to article page